Loading news...
Series C funding round for ENYO Pharma raising $28M in January 2024
Series C funding round for ENYO Pharma raising $28M in January 2024
| Investor | Firm Type | Partner |
|---|
OrbiMedLEAD | Venture Capital | — |
MorningsideLEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Vincent Brichard |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$102M
Top Valuation
-
ENYO Pharma raised $28M in a Series C round.
The round was announced on 01/01/24.
The round was led by OrbiMed, Morningside Ventures.